EUVIMEDEUVIMED entdecken
Crossref

Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway

Pratikshya Sa, Priya Singh, Sudhakar Panda, Rajeeb K Swain, Rupesh Dash, Sanjeeb Kumar Sahoo

Translational Research · 2024

DOI: 10.1016/j.trsl.2024.03.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2024. Verfasst von Pratikshya Sa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Life Sciences, Nalco square, Chandrasekharpur, Bhubaneswar, Odisha 751 023, India; Regional Centre for Biotechnology, Faridabad-Gurgaon …. Hauptthemen laut MEDLINE: Cisplatin, Nanoparticles, Dioxolanes, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research, India, Regional Centre for Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin alone or in combination with 5FU and docetaxel is the preferred chemotherapy regimen for advanced-stage OSCC patients. However, its use has been linked to recurrence and metastasis due to the development of drug resistance. Therefore, sensitization of cancer cells to conventional chemotherapeutics can be an effective strategy to overcome drug resistance. Piperlongumine (PL), an alkaloid, have shown anticancer properties and sensitizes numerous neoplasms, but its effect on OSCC has not been explored. However, low aqueous solubility and poor pharmacokinetics limit its clinical application. Therefore, to improve its therapeutic efficacy, we developed piperlongumine-loaded PLGA-based smart nanoparticles (smart PL-NPs) that can rapidly release PL in an acidic environment of cancer cells and provide optimum drug concentrations to overcome chemoresistance. Our results revealed that smart PL-NPs has high cellular uptake in acidic environment, facilitating the intracellular delivery of PL and sensitizing cancer cells to cisplatin, resulting in synergistic anticancer activity in vitro by increasing DNA damage, apoptosis, and inhibiting drug efflux. Further, we have mechanistically explored the Hippo-YAP signaling pathway, which is the critical mediator of chemoresistance, and investigated the chemosensitizing effect of PL in OSCC. We observed that PL alone and in combination with cisplatin significantly inhibits the activation of YAP and its downstream target genes and proteins. In addition, the combination of cisplatin with smart PL-NPs significantly inhibited tumor growth in two preclinical models (patient-derived cell based nude mice and zebrafish xenograft). Taken together, our findings suggest that smart PL-NPs with cisplatin will be a novel formulation to reverse cisplatin resistance in patients with advanced OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinNanoparticlesDioxolanesDrug Resistance, NeoplasmMouth NeoplasmsSignal TransductionHippo Signaling PathwayProtein Serine-Threonine KinasesHumansAnimalsCell Line, TumorZebrafishCarcinoma, Squamous CellAntineoplastic AgentsApoptosisTranscription FactorsMice, NudeMiceYAP-Signaling ProteinsXenograft Model Antitumor AssaysAdaptor Proteins, Signal TransducingPiperidones

Stichwörter der Autor:innen

ChemoresistanceNanomedicineOral squamous cell carcinomaPiperlongumineYAP

Substanzen

piperlongumineCisplatinDioxolanesProtein Serine-Threonine KinasesAntineoplastic AgentsTranscription FactorsYAP1 protein, humanYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingPiperidones

Autor:innen und Institutionen

  • Institute of Life Sciences, Nalco square, Chandrasekharpur, Bhubaneswar, Odisha 751 023, India; Regional Centre for Biotechnology, Faridabad-Gurgaon Expressway, Faridabad, Haryana 121 001, India.
  • Institute of Life Sciences, Nalco square, Chandrasekharpur, Bhubaneswar, Odisha 751 023, India.
  • Institute of Life Sciences, Nalco square, Chandrasekharpur, Bhubaneswar, Odisha 751 023, India. Electronic address: sanjeeb@ils.res.in.

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India
  • Council of Scientific and Industrial Research, India
  • Regional Centre for Biotechnology
  • Life Sciences Institute

Zitieren

APA

Sa, P., Singh, P., Panda, S., Swain, R. K., Dash, R., & Sahoo, S. K. (2024). Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway. Translational Research. https://doi.org/10.1016/j.trsl.2024.03.004

Vancouver

Sa P, Singh P, Panda S, Swain RK, Dash R, Sahoo SK. Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway. Translational Research. 2024. doi:10.1016/j.trsl.2024.03.004

BibTeX
@article{Sa2024,
  author = {Sa, Pratikshya and Singh, Priya and Panda, Sudhakar and Swain, Rajeeb K and Dash, Rupesh and Sahoo, Sanjeeb Kumar},
  title = {Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway},
  journal = {Translational Research},
  year = {2024},
  doi = {10.1016/j.trsl.2024.03.004}
}
Kostenlos starten →